πŸ‡ΊπŸ‡Έ FDA
Patent

US 7713973

Kinase inhibitors

granted A61PA61P1/00A61P15/18

Quick answer

US patent 7713973 (Kinase inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P1/00, A61P15/18, A61P17/06, A61P17/14